gabapentine in muscle tension dysphonia

Investigating Oral gabapentine effect on voice quality of patient's with muscle tension dysphonia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210320050749N1

Enrollment

Registered

2021-04-15

Start date

2021-04-20

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle tension dysphonia. Dysphonia

Interventions

Intervention 1: Intervention group:Taking gabapentin 100 mg daily for two months and re-stroboscopic examination. Intervention 2: Control group: Taking pelacebo For three months and re-stroboscopic e

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with functional voice disorder

Exclusion criteria

Exclusion criteria: Diagnosis of organic laryngeal disorder

Design outcomes

Primary

Measure	Time frame
Stroboscopic score. Timepoint: Stroboscopic score before and two months after treatment. Method of measurement: Stroboscopic score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoraya Ahmadi

Shahid Beheshti University of Medical Sciences

md.s.ahmady@gmail.com+98 31 3673 6377

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026